| Drug Name |
Lymecycline |
| Drug ID |
BADD_D01333 |
| Description |
Lymecycline is a broad-spectrum second-generation tetracycline antibiotic used for the treatment of acne and other susceptible bacterial infections.[L13880,L13883] It has been proven a cost-effective alternative to treatment with [minocycline] with comparable safety and efficacy.[A203255] Lymecycline was initially discovered in 1961. It is marketed by Galderma and used in the UK as well as New Zealand in addition to other countries. Lymecycline is not marketed in the USA, however, equivalent drugs are available, such as minocycline and [tetracycline].[A19429,L13880] |
| Indications and Usage |
Lymecycline is used for the treatment of acne in addition to other susceptible infections; propionibacterium is often the cause of acne.[L13880] Some of the infections that can be treated with lymecycline include upper respiratory tract infections, urinary tract infections, bronchitis, chlamydial infections, and rickettsial infections.[L13883] |
| Marketing Status |
approved; investigational |
| ATC Code |
J01AA04 |
| DrugBank ID |
DB00256
|
| KEGG ID |
D06884
|
| MeSH ID |
D008194
|
| PubChem ID |
54707177
|
| TTD Drug ID |
D04VEJ
|
| NDC Product Code |
Not Available |
| UNII |
7D6EM3S13P
|
| Synonyms |
Lymecycline | N-Lysinomethyltetracycline | N Lysinomethyltetracycline | Tetracyclinemethylene Lysine | Lysine, Tetracyclinemethylene | Tetracycline-L-Methylene Lysine | Lysine, Tetracycline-L-Methylene | Tetracycline L Methylene Lysine | Lymecycline Hydrochloride | Hydrochloride, Lymecycline |
